EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Tyrosine Phosphatases in the HER2-Directed Motility of Ovarian Cancer Cells: Involvement of PTPN12, ERK5 and FAK

Emma Villa-Moruzzi

Analytical Cellular Pathology · 2011 · 34 (3) · 101-112

DOI: 10.1155/2011/870459 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2011. Verfasst von Emma Villa-Moruzzi. Die Arbeit wurde bisher 25-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Associazione Italiana per la Ricerca sul Cancro.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

HER2 activation in tumours supports multiple signalling pathways, including those regulating invasion and metastasis. Among the involved genes, Tyrosine and Dual Specificity Phosphatases (PTPs and DSPs) may play a relevant, though not completely clear role.

Methods

HER2 was silenced in ovarian SKOV-3 cells, a genome-wide expression analysis of PTPs and DSPs was performed, the effects on cell motility were analysed and compared with those of PTPN12-silencing, focusing on FAK.

Results

HER2-silencing altered the expression of 4 PTPs and 6 DSPs; PTPN12 displayed also 3-4-fold protein increase. Conversely, PTPN12-silencing enhanced migration, suggesting that PTPN12 down-modulation by HER2 favours motility. HER2-silencing inactivated FAK, in quiescent and migrating cells, involving FAK dephosphorylation at Y397 and S910. Conversely, in PTPN12-silenced cells FAK activity was close to control, altogether suggesting that PTPN12 targets Y397. As regards to S910, cell-treatment with the MEK inhibitor UO126 and ERK5-silencing indicated its targeting by ERK5. Loss of pS910 and decreased ERK5 kinase activity in HER2-silenced cells confirmed their control by HER2.

Conclusions

The results indicate the contribution of PTPN12, targeting FAK Y397, and ERK5, targeting FAK S910, to the HER2-driven cell motility, thus depicting new aspects of the complex cross­talk between HER2 and the motility machinery.

Förderung

  • Associazione Italiana per la Ricerca sul Cancro

Zitieren

APA

Villa-Moruzzi, E. (2011). Tyrosine Phosphatases in the HER2-Directed Motility of Ovarian Cancer Cells: Involvement of PTPN12, ERK5 and FAK. Analytical Cellular Pathology, 34(3), 101-112. https://doi.org/10.1155/2011/870459

Vancouver

Villa-Moruzzi E. Tyrosine Phosphatases in the HER2-Directed Motility of Ovarian Cancer Cells: Involvement of PTPN12, ERK5 and FAK. Analytical Cellular Pathology. 2011;34(3):101-112. doi:10.1155/2011/870459

BibTeX
@article{VillaMoruzzi2011,
  author = {Villa-Moruzzi, Emma},
  title = {Tyrosine Phosphatases in the HER2-Directed Motility of Ovarian Cancer Cells: Involvement of PTPN12, ERK5 and FAK},
  journal = {Analytical Cellular Pathology},
  year = {2011},
  volume = {34},
  number = {3},
  pages = {101--112},
  doi = {10.1155/2011/870459}
}
Kostenlos starten →